DARE BIOSCIENCE, INC. (DARE)
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
📈 **POSITIVE** • Medium confidence analysis (63%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (76%) **Content type:** Clinical